SCHEMBL24143555

SCHEMBL24143555

COc1cccc(Cn2cc(CCN)c3ccc(-c4ccncc4)cc32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 7/20 0.46
▸ ROCK1 Q13464 4/20 0.46
▸ MAOB P27338 2/20 0.46
▸ EGFR P00533 1/20 0.45
▸ IGF1R P08069 1/20 0.45
▸ FLT4 P35916 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ TAAR1 Q96RJ0 1/20 0.44
▸ KMT2A Q03164 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ PRKACA P17612 1/20 0.42
▸ GSK3A P49840 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ PRKX P51817 1/20 0.42
▸ PRKCQ Q04759 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ NR1D1 P20393 2/20 0.42
▸ HTR6 P50406 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24144070 0.85 HTR6 (0.54) EGFRIGF1RFLT4KDRNR1D1
SCHEMBL24144383 0.85 CYP19A1 (0.49) EGFRIGF1RFLT4KDRTAAR1
SCHEMBL24144290 0.85 HTR6 (0.41) ROCK2ROCK1EGFRIGF1RFLT4
SCHEMBL24144386 0.85 LMNA (0.45) MAOBEGFRIGF1RFLT4KDR
SCHEMBL24144502 0.85 CYP19A1 (0.47) ROCK2ROCK1EGFRIGF1RFLT4
SCHEMBL24143220 0.82 NR1D1 (0.67) NR1D1
SCHEMBL24143551 0.82 NR1D1 (0.41) EGFRIGF1RFLT4KDRNR1D1
SCHEMBL24144381 0.82 ICMT (0.50) ROCK2ROCK1MAOBEGFRIGF1R
SCHEMBL24143548 0.79 NFATC1 (0.50) MAOBEGFRIGF1RFLT4KDR
SCHEMBL24143743 0.78 NR1D1 (0.50) ROCK2ROCK1PRKACAGSK3ANR1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback